Text: Summary Paragraph
Early embryogenesis involves a series of dynamic processes, many of which are currently not well described or understood. Aneuploidy and aneuploid mosaicism, a mixture of aneuploid and euploid cells within one embryo, in early embryonic development are principal causes of developmental failure.
1,2 Here we show that human embryos demonstrate a significant rate of genetic correction of aneuploidy, or "genetic normalization" when cultured from the cleavage populations. An additional three Blastocyst stage embryos showed genetic correction of the TE but not the ICM and one Blastocyst stage embryo showed the reverse. Mosaicism (exceeding 5%), was not detected in any of the ICM and TE samples analyzed. Recognizing that genetic normalization may occur in developing human embryos has important implications for stem cell biology, preimplantation and developmental genetics, embryology, and reproductive medicine.
Text: Body
Spontaneous miscarriages in human pregnancies have been well documented to be associated with chromosomal aneuploidy. 1, 2 In an attempt to minimize rates of aneuploidy in high risk pregnancies, single cells can be biopsied from early embryos and tested for their chromosome complement prior to uterine transfer. 3 This procedure, termed PGS, is generally performed on polar bodies or 1-2 totipotent blastomere cells biopsied from Cleavage stage embryos. 3 The traditional modality for evaluating the chromosomal makeup of these cells has been by fluorescence in situ hybridization (FISH) of 5-12 chromosomes. Plausible explanations for the genetic normalization observed in this study must account for the fate of aneuploid cells within the Cleavage stage embryo. It remains possible that a small number of aneuploid cells are preferentially relegated to the TE resulting in low level mosaicism below our detection threshold of 5% (See Methods Section). However, the proportion of detected aneuploidy in the TE was lower (rather than higher) compared to the ICM cell populations. As mosaicism is known to exist in Cleavage stage embryos, 6, 7 it is also possible that the removal of the only abnormal cell from the mosaic embryo at Cleavage stage leaves only euploid cells behind. However, if only 1 cell in a Cleavage stage embryo were aneuploid, the chance of repeatedly removing only this cell from multiple embryos is exceedingly low. Indeed, our data shows that Cleavage stage embryos, diagnosed via a single cell molecular karyotype, as euploid progressed to the Blastocyst stage at a rate of 69.4% compared with only 39.1% of aneuploid embryos. It is possible that some level of mosaicism is common among developing embryos.
One could postulate that low levels of mosaicism translate into a higher rate of development to the blastocyst stage. Our data could be consistent with this hypothesis given that, if mosaicism was present in many of the embryos evaluated, one would be more likely to have an aneuploid cell obtained during biopsy compared to embryos with higher levels of euploidy.
Our data suggests that a possible mechanism for the embryo correction seen in this study is the loss of aneuploid cells within developing mosaic Cleavage stage embryos. Indeed, most of the corrections observed would be extremely difficult to rationalize by a mechanism that accounts for the correction of multiple chromosomes. Rather, it appears likely that there may exist in early human embryonic development a drive toward normalization in which aneuploid cells are systematically marginalized. Aneuploid cells within the embryo may undergo apoptosis, thereby leaving euploid cells in the surviving Blastocyst stage embryo. In aneuploid cells, genes such as those coding for the checkpoint proteins Bub and Mad could initiate apoptotic mechanisms rather than those that lead to mitotic cell division. 20 Another possibility, although unlikely, is that aneuploid cells may replicate less efficiently than euploid cells resulting in their eventual loss within the developing embryo. There could also be as yet unidentified mechanisms that correct aneuploidy during early embryologic development. It is also conceivable that correction of aneuploidy in a subset of cells within Cleavage stage embryos is a normal event in early embryogenesis.
The concept of embryo normalization has been postulated previously. 21 The genetic normalization observed in this study has significant implications in numerous scientific fields. A current challenge within stem cell biology is the high rate of acquired aneuploidy that is observed with cell colonies in extended culture. 26, 27, 28, 29 Dissecting the mechanism underlying the normalization observed in this study in a stem cell system would be highly useful and may be applied to cell-based therapeutic approaches using stem cells. amplification, microarray analyses, and scanning as described above. Our laboratory identifies mosaic cell populations at a level of 5% (See Methods Section).
All coded and de-identified samples were kept by an individual not responsible for molecular karyotype interpretation. Molecular data was analyzed in a blinded manner as described above.
The samples were then de-identified and data tabulated. Binomial confidence intervals for proportions were calculated by the modified Wald method. Immunocytochemistry was performed on an aliquot of cells from each tube using anti-oct3/4 to confirm the identity of the ICM and anti-cdx2 to confirm the TE cells. DNA amplification, microarray analyses and scanning was then performed as described above. Embryos that failed to develop to the Blastocyst stage were unable to be analyzed due to high levels of cellular fragmentation and embryo degeneration.
Text: Methods Section Details Materials and Methods for the Data Described in this Paper
All coded and de-identified samples were kept by an individual not responsible for molecular karyotype interpretation. The Blastocyst stage ICM and TE microarray interpretations were performed blinded to all corresponding patient or embryo information. These interpretations were repeated by the same blinded reader four separate times, confirming the integrity of the results with all data analyzed. The samples were then de-identified and data tabulated. Binomial confidence intervals for proportions were calculated by the modified Wald method. 
Detailed Materials and Methods Describing Single Cell Microarray Validation and Clinical

PGS Results
Development and Validation of Single Cell Microarray Protocol
In our development of single cell microarray analysis, a DNA amplification protocol was optimized that does not include polymerase chain reaction (PCR) technology as this introduces an unacceptable level of artifact and compromises diagnostic integrity. We developed our 23 chromosome SNP microarray protocol to include a modified multiple displacement amplification using phi 29 polymerase followed by a whole genome amplification protocol on a single cell. Additionally, extensive bioinformatic analysis was used to create an embryonic SNP genotype normalized data set. This data set was then compared against clinical samples to identify normal and abnormal SNP genotypes in individual embryonic cells.
Prior to launching our clinical PGS program, after which time the experiments described in this manuscript were performed, our laboratory underwent an extensive validation process on 802 cells from 110 cleavage stage embryos that were evaluated clinically by 10-probe FISH for PGS. with all cells missing the tested chromosome. Additionally, the B allele frequency will shift depending upon the percent of the genotype of the remaining allele. For mosaic trisomies, the log R ratio will show an increase in copy number and the B allele frequency will shift depending upon the genotype of the remaining allele. If shifts are observed in the b allele frequency but without alterations in the smooth log R ratio, this indicates mosaicism and uniparental disomy.
Our lab has tested > 40 aneuploid mosaic cell populations and we detect monosomic and / or trisomic mosaicism at the level of 5%. 1A shows the normal diploid diagnostic reading obtained from an ICM cell population for chromosome #1. Normal AA, AB and BB alleles and a 0 reading for the smooth log R ratio is observed.
1B represents the normal diploid reading of chromosome 12, from a TE cell population. Normal AA, AB and BB alleles and a 0 reading for the smooth log R ratio is observed.
For both 1A and 1B, no shifts are observed in the smooth log R ratio or B allele frequency, therefore no mosaicism is identified by our laboratory threshold of 5% of cells analyzed (see detailed methods section for a description of mosaicism).
1C demonstrates X/XX chromosome mosaicism and uniparental disomy from an amniocentesis case not included in this study. Evident are shifts in the b allele frequency. In this case, no significant shift is observed in the smooth log R ratio, indicating uniparental disomy. The diagnosis of this cell population is approximately 90% X bearing cells and approximately 10% XX bearing cells. This image has been included to illustrate our ability to identify low level mosaicism within a cell population.
1D demonstrates a monosomy reading of chromosome 18, from a Cleavage stage embryo. A and B alleles are observed without AB alleles represented. A significant shift in the smooth log R ratio is observed, consistent with the monosomy karyotype. This figure accounts for fate of all of the embryos included in the study. Molecular karyotypes were obtained at the Cleavage stage for all embryos. Cleavage stage embryos with a euploid diagnosis that progressed to the Blastocyst stage were not subjected to further biopsy or intervention and were available for uterine transfer or cryopreservation. Cleavage stage embryos with an aneuploid diagnosis that progressed to the Blastocyst stage underwent embryo surgery at which point repeated molecular karyotypes were obtained from the ICM and TE cell populations. Development of Evaluated Embryos
